Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Business Currents.
Press releases published on May 27, 2025
Enlight Announces Conference Call to Discuss “Enlight and the IRA Transition” on May 29, 2025
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, "the Company”, NASDAQ: ENLT, TASE: ENLT.TA), a leading renewable energy platform, announces that it will host a conference call to discuss “Enlight and the IRA …
SONSIEL and The DAISY Foundation Celebrate Nurse Innovation at THInC with Inaugural DAISY Awards
EIN Presswire
·
May 27, 2025
BOSTON, MA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In a landmark moment for nursing innovation and recognition, the Society of Nurse Scientists, Innovators, Entrepreneurs, and Leaders (SONSIEL) and The DAISY Foundation proudly presented the …
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
GlobeNewswire
·
May 27, 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …
UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2025 INVESTOR CONFERENCE
GlobeNewswire
·
May 27, 2025
FREEHOLD, NJ, May 27, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), today announced that the Company will participate in Nareit’s REITweek: 2025 Investor Conference, to be held in New York City, at the New York Hilton Midtown. UMH’ …
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
GlobeNewswire
·
May 27, 2025
BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseases BD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targets Collaboration builds on …
Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions
GlobeNewswire
·
May 27, 2025
PETAH TIKVA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Commercial Division received over $25 …